All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia?

Author(s): Kamini J

The objective of chronic myeloid leukemia treatment is to remove the platelets that contain the strange BCR-ABL gene that causes the high number of infected platelets. For the vast majority, it's unrealistic to dispose of every sick cell, yet treatment can accomplish a long haul remission of the disease. The meds utilized for patients with ceaseless (Chronic) stage interminable myelogenous leukemia (CML) go for postponing the onset of the quickened or blastic phase. This has generally incorporated a myelosuppressive operator to accomplish hematologic abatement, yet more compelling medications-progressively, interferon Alfa then and focused on treatment with tyrosine kinase inhibitors, for example, imatinib mesylate, have increased more noteworthy significance. Imatinib is a protein-tyrosine kinase inhibitor. It works by keeping the development of malignancy cells.


Share this       

Select your language of interest to view the total content in your interested language

Table of Contents

Google Scholar citation report
Citations : 17

Biochemistry & Molecular Biology Letters received 17 citations as per Google Scholar report

Indexed In

  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)

Read More

Flyer
Globaltech